CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-28 | Bencich John CEO | Option exercise · Performance Restricted Stock Unit (PRSU) | −7,500 | 0 | ||
| 2023-04-28 | Stewart Richard Alistair Executive Chairman | Option exercise | +5,000 | 30,751 | ||
| 2023-04-28 | Stewart Richard Alistair Executive Chairman | Shares withheld for taxes | −2,250 | $8.29 | $19K | 28,501 |
| 2023-04-28 | Stewart Richard Alistair Executive Chairman | Option exercise · Performance Restricted Stock Unit (PRSU) | −5,000 | 0 | ||
| 2023-04-21 | Bencich John CEO | Shares withheld for taxes | −5,863 | $6.80 | $40K | 56,057 |
| 2023-04-21 | JACOBS CINDY President & CMO | Shares withheld for taxes | −3,811 | $6.80 | $26K | 16,370 |
| 2023-04-21 | Wan Jerry Principal Accounting Officer | Option exercise | +5,625 | 8,861 | ||
| 2023-04-21 | Wan Jerry Principal Accounting Officer | Shares withheld for taxes | −3,010 | $6.80 | $20K | 5,851 |
| 2023-04-21 | Wan Jerry Principal Accounting Officer | Option exercise · Performance Restricted Stock Unit (PRSU) | +5,625 | 5,625 | ||
| 2023-04-21 | Stewart Richard Alistair Executive Chairman | Option exercise | +22,500 | 35,876 | ||
| 2023-04-21 | Stewart Richard Alistair Executive Chairman | Shares withheld for taxes | −10,125 | $6.80 | $69K | 25,751 |
| 2023-04-21 | Stewart Richard Alistair Executive Chairman | Option exercise · Performance Restricted Stock Unit (PRSU) | +22,500 | 22,500 | ||
| 2023-04-21 | JACOBS CINDY President & CMO | Option exercise | +16,250 | 20,181 | ||
| 2023-04-21 | JACOBS CINDY President & CMO | Shares withheld for taxes | −4,819 | $6.80 | $33K | 15,362 |
| 2023-04-21 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | +16,250 | 16,250 | ||
| 2023-04-21 | Bencich John CEO | Option exercise | +25,000 | 61,920 | ||
| 2023-04-21 | Bencich John CEO | Shares withheld for taxes | −7,324 | $6.80 | $50K | 54,596 |
| 2023-04-21 | Bencich John CEO | Option exercise · Performance Restricted Stock Unit (PRSU) | +25,000 | 25,000 | ||
| 2023-03-29 | KING THOMAS BRAXTON Director | Grant or award · Stock Option (right to buy) | +23,250 | 23,250 | ||
| 2023-03-29 | Sellig Thomas Director | Grant or award · Stock Option (right to buy) | +23,250 | 23,250 |
Page 7 of 36 · 715 trades